These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26784680)

  • 21. Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.
    Cheng VE; Oppermen A; Natarajan D; Haikerwal D; Pereira J
    Heart Lung Circ; 2014 Apr; 23(4):e115-7. PubMed ID: 24480082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery.
    Capodanno D; Musumeci G; Lettieri C; Limbruno U; Senni M; Guagliumi G; Valsecchi O; Angiolillo DJ; Rossini R
    Thromb Haemost; 2015 Aug; 114(2):423-31. PubMed ID: 26017898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ideal antiplatelet therapy for coronary artery disease: focus on adenosine diphosphate receptor inhibitors.
    Chandrasekar S; Loomba R; Shah P; Arora R
    Am J Ther; 2013; 20(4):337-43. PubMed ID: 21519219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New anti-platelet agents: the end of resistance?
    Kastrati A
    Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology.
    Barillà F; Pelliccia F; Borzi M; Camici P; Cas LD; Di Biase M; Indolfi C; Mercuro G; Montemurro V; Padeletti L; Filardi PP; Vizza CD; Romeo F;
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18(1):1-9. PubMed ID: 27635937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy.
    Whitmore TJ; O'Shea JP; Starac D; Edwards MG; Waterer GW
    Chest; 2014 Mar; 145(3):639-641. PubMed ID: 24590025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin.
    Agarwal SK
    Cardiovasc Revasc Med; 2014; 15(5):308-10. PubMed ID: 24880912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management after coronary stent implantation: a review.
    Brilakis ES; Patel VG; Banerjee S
    JAMA; 2013 Jul; 310(2):189-98. PubMed ID: 23839753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction.
    Oualim S; Elharda CA; Benzeroual D; Hattaoui ME
    Pan Afr Med J; 2016; 24():308. PubMed ID: 28154663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
    Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
    Pandit A; Giri S; Hakim FA; Fortuin FD
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
    Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK;
    Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: boon and bane of a new drug.
    Schotola H; Bräuer A; Meyer K; Hinz J; Schöndube FA; Bauer M; Mohite PN; Danner BC; Sossalla S; Popov AF
    Eur J Cardiothorac Surg; 2014 Aug; 46(2):198-205. PubMed ID: 24420365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.
    Brener SJ; Serruys PW; Morice MC; Mehran R; Kappetein AP; Sabik JF; Liu Y; Dressler O; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Oct; 72(17):2086-2087. PubMed ID: 30336833
    [No Abstract]   [Full Text] [Related]  

  • 37. Ticagrelor: the silence of the platelets.
    Laine M; Paganelli F; Bonello L
    Expert Opin Pharmacother; 2013 Feb; 14(2):151-3. PubMed ID: 23294190
    [No Abstract]   [Full Text] [Related]  

  • 38. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
    Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ticagrelor. Acute coronary syndromes: nothing new.
    Prescrire Int; 2011 Oct; 20(120):229-33. PubMed ID: 21970081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.